Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SGNBB-228 by Pfizer for Non-Small Cell Lung Cancer: Likelihood of Approval
SGNBB-228 is under clinical development by Pfizer and currently in Phase I for Non-Small Cell Lung Cancer. According to GlobalData,...
Data Insights
SGNBB-228 by Pfizer for Metastatic Melanoma: Likelihood of Approval
SGNBB-228 is under clinical development by Pfizer and currently in Phase I for Metastatic Melanoma. According to GlobalData, Phase I...